Presentations

 
2007     2006     2005     2004     2003     2002     2001     2000     1999     1998     1997     1996
 
     
  DCOR Study: Assessing impact of sevelamer vs calcium binders onhospitalization & morbidity in hemodialysis patients using CMS data.
 
  Wendy St. Peter, PharmD1,2, Jiannong Liu, PhD1, Qiao Fan, MS1, Eric Weinhandl, MS1  
  Journal of the American Society of Nephrology 39th Annual Meeting, San Diego, CA, November, 2006  
     
  DCOR Study: Assessing economic impact of sevelamer vs calcium binder on hospitalization & morbidity in hemodialysis patients using CMS data.
 
  Wendy L. St. Peter, PharmD1,2, Jiannong Liu, PhD1, Qiao Fan, MS1, Eric Weinhandl, MS1  
  Journal of the American Society of Nephrology 39th Annual Meeting, San Diego, CA, November, 2006  
     
  Pre-ESRD erythropoietin treatment & associated hospitalization & mortality outcomes after dialysis initiation.
 
  Tricia Roberts, MS, David Gilbertson, PhD, Allan Collins, MD, FACP  
  Journal of the American Society of Nephrology 39th Annual Meeting, San Diego, CA, November, 2006  
     
  Consistency of pre-ESRD erythropoietin use & hospital days at & following hemodialysis initiation.
 
  Tricia Roberts, MS, Anne Murray, MD, MSc, David Gilbertson, PhD, Allan Collins, MD, FACP  
  Journal of the American Society of Nephrology 39th Annual Meeting, San Diego, CA, November, 2006  
     
  Levocarnitine use is causally associated with a reduction in subsequent hospitalization days.
 
  Eric Weinhandl, MS, Allan Collins, MD, FACP, David Gilbertson, PhD, Brian Pereira, MD  
  Journal of the American Society of Nephrology 39th Annual Meeting, San Diego, CA, November, 2006  
     
  Predictors of ESP use in the non-dialysis CKD population with anemia.
 
  Haifeng Guo, MS,* David Gilbertson, PhD,* Brian Bradbury, DSc,† Stephan Dunning, MGIS,* Allan Collins, MD, FACP*  
  Journal of the American Society of Nephrology 39th Annual Meeting, San Diego, CA, November, 2006  
     
  Association between missed dialysis sessions & hemoglobin variability in the U.S.
 
  Robert Foley, MB, MSc, Qi Li, MSc, David Gilbertson, PhD, Allan Collins, MD, FACP, Stephan Dunning, MGIS  
  Journal of the American Society of Nephrology 39th Annual Meeting, San Diego, CA, November, 2006  
     
  The incidence & progression of cognitive impairment in hemodialysis patients.
 
  Anne Murray, MD, MSc, Sarah Pederson, MA, David Tupper, Yang Qiu, MS, Allan Collins, MD, FACP  
  Journal of the American Society of Nephrology 39th Annual Meeting, San Diego, CA, November, 2006  
     
  The association of persistently low hemoglobin levels with medical expenditures in dialysis patients.
 
  Jiannong Liu, PhD, Haifeng Guo, MS, David Gilbertson, PhD, Allan Collins, MD, FACP  
  Journal of the American Society of Nephrology 39th Annual Meeting, San Diego, CA, November, 2006  
     
  The effect of hemoglobin variability & trends on mortality.
 
  David Gilbertson, PhD1, James Ebben, BS1, Brian Bradbury, DSc2, Stephan Dunning, MGIS1, Allan Collins, MD, FACP1  
  Journal of the American Society of Nephrology 39th Annual Meeting, San Diego, CA, November, 2006  
     
     
 
CDRG - 914 South 8th Street - Suite S-206 - Minneapolis, MN 55404 - (612) 347-3903